Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|May 6, 2026
Epigenetic reprogramming of hepatic antigen presenting cells in chronic liver diseaseEnrique Ángel-Gomis, Oriol Juanola, Esther Caparrós, et al.
Hepatology Communications|May 22, 2026
Epigenetic drug control of Clec4g/LSECtin expression reduces fibrosis burden in cirrhosisEnrique Ángel-Gomis, Isabel Gómez-Hurtado, Maite G Fernández-Barrena, et al.
Dermatology (Basel, Switzerland)|June 23, 2025
Interleukin-36 Gamma Measurement via Tape Stripping for Distinguishing Paediatric Psoriasis from Atopic DermatitisAlexandre Docampo-Simón, Isabel Belinchón-Romero, María José Sánchez-Pujol, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 21, 2025
Antagonizing epigenetically controlled PAF/PAF-R pathway improves liver function during experimental cirrhosisEnrique Ángel-Gomis, Esther Caparrós, Isabel Gómez-Hurtado, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2024
Cirrhosis-downregulated LSECtin can be retrieved by cytokines, shifts the TLR-induced LSECs secretome and correlates with the hepatic Th responseSebastián Martínez-López, Enrique Ángel-Gomis, Isabel Gómez-Hurtado, et al.
JHEP Reports : Innovation in Hepatology|August 14, 2025
LSECtin attenuates hepatic Th17 expansion in a murine model of cirrhosis and signals through the LAG-3 receptorSebastián Martínez-López, Oriol Juanola, Isabel Gómez-Hurtado, et al.
Pageof 1